Advertisement

Drugs

, Volume 79, Issue 16, pp 1739–1739 | Cite as

Correction to: As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?

  • Christian DomingoEmail author
  • Jordi Rello
  • Ana Sogo
Correction
  • 285 Downloads

1 Correction to: Drugs (2019)  https://doi.org/10.1007/s40265-019-01202-0

Abstract, fourth to last sentence, which currently reads:

Despite this poor evidence, and ignoring the clinical histological benefits of chronic inhaled corticosteroids (especially when administered promptly), GINA 2019 recently recommended daily low dose ICS or ICS–ICS as needed as a first option for step 2 patients.

Should read:

Despite this poor evidence, and ignoring the clinical histological benefits of chronic inhaled corticosteroids (especially when administered promptly), GINA 2019 recently recommended daily low dose ICS or ICS-LABA as needed as a first option for step 2 patients.

The original article has been corrected.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Servei de PneumologiaCorporació Sanitària Parc TaulíSabadell (Barcelona)Spain
  2. 2.Departament de MedicinaUniversitat Autònoma de Barcelona (UAB)BarcelonaSpain
  3. 3.CIBERES, Instituto Salud Carlos III and Vall d’Hebron Institute of ResearchBarcelonaSpain

Personalised recommendations